Delivery Order SPE2DB24D2010-SPE2DB24FZWU7

Award Date 8/8/24
Potential Completion Date 8/9/24
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,467.74 firm-fixed-price delivery order is for the supply of 4565532788 VYVANSE 30 MG CAPSULE 100S, a pharmaceutical product. This award is not associated with any set-aside program. The contract has an ultimate completion date of August 22, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds several indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,873.63 firm fixed-price delivery order is for the supply of VYVANSE 20 MG CAPSULE 100S, a prescription medication. The contract has an ultimate completion date of January 8, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor, is a Delivery Order valued at $2,785.90 from the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of VYVANSE 50 MG CAPSULE 100S, a prescription medication, to support various government healthcare programs and military treatment facilities. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,886,214 units of the pharmaceutical product VYVANSE 20 MG CAPSULE 100S. The $1,099.48 firm fixed price award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a civilian agency of the U.S. Department of Defense, on June 12, 2024 with a completion date of June 13, 2024. This order is placed against Amerisourcebergen's Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $1,390.08 Firm Fixed Price Delivery Order is for the supply of 4565403728 - VYVANSE 50 MG CAPSULE 100S, with an ultimate completion date of August 12, 2024. This award is not associated with a set-aside program. Amerisourcebergen holds a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, is for the delivery of VYVANSE 30 MG CAPSULE 100S to the Defense Logistics Agency (DLA). The contract, valued at $5,433.46, is a Firm Fixed Price Delivery Order with a completion date of June 28, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,052.30 firm fixed-price delivery order is for the supply of VYVANSE 20 MG CAPSULE 100S, a prescription medication. The contract has an ultimate completion date of May 22, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,902.66 Firm Fixed Price delivery order is for the supply of VYVANSE 20 MG CAPSULE 100S, a pharmaceutical product. The contract has an ultimate completion date of February 25, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $2,364.40 firm fixed price delivery order is for the supply of 4564743413 - VYVANSE 50 MG CAPSULE 100S, a prescription medication. The award date is May 29, 2024, with a completion date of May 30, 2024. This contract has no set-aside designation. Amerisourcebergen is a major pharmaceutical distribution company that holds a $999,999,999.00 Indefinite...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,366.48 firm fixed price delivery order is for the supply of VYVANSE 50 MG CAPSULE 100S, a prescription medication. The award has an ultimate completion date of August 16, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
  • SPE2DB24D2010
    Indefinite Delivery Contract
  • SPE2DB24D2010-SPE2DB24FZWU7
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division was made by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,898.76 Firm Fixed Price Delivery Order is for the supply of 4565392643 VYVANSE 20 MG CAPSULE 100S, a prescription medication. The contract has an ultimate completion date of August 9, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999 and $750,000 respectively, for providing a wide range of medical commodities to support military, veterans, and other government healthcare programs. This specific award is not associated with a set-aside designation.

Generated 11/7/24, 9:03 AM